前侧注意力系统在帕金森病中的疗效:波兰的一项横截面研究
Paulina Beata Golińska-Drobienko1, Artur Sawicki1, Łucja Bieleninik1
1Faculty of Social Science, Institute of Psychology, University of Gdańsk, Gdańsk, Poland.
Frontiers in human neuroscience
|December 1, 2025
概括
患有痴呆症的帕金森病患者在前侧注意系统中表现出显著的缺陷. 轻度认知障碍和正常认知在很大程度上被保留,这表明注意力系统受到疾病严重程度的影响.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 认知科学 认知科学
背景情况:
- 认知障碍是帕金森病 (PD) 的常见非运动症状,影响患者的生活质量.
- 执行功能缺陷是一个关键问题,但它们与PD中的特定认知状态的联系需要进一步调查.
研究的目的:
- 研究帕金森病患者的认知状态 (正常认知,轻度认知障碍,轻度痴呆) 与他们在前侧注意力系统上的表现之间的关联.
- 了解帕金森病中不同程度的认知障碍如何影响与注意力相关的执行功能.
主要方法:
- 一项涉及96名帕金森病患者 (分为PD-正常认知状况,PD-轻度认知障碍,PD-痴呆症) 和46名对照者的横截面研究.
- 认知状态评估使用迷你心理状态检查,口头学习,数字跨度,雷伊复杂图形和Trail Making测试.
- 罗特曼湾电池评估了前侧注意力系统.
主要成果:
- 患有帕金森病痴呆症 (PDD) 的人在前侧注意力系统中表现出显著的损伤.
- 在PD-轻度认知障碍 (PD-MCI) 和PDD组中,能量化过程略有受损.
- 监测和任务设置功能仅在PDD组中显著受损.
结论:
- 前侧注意系统在帕金森病患者中通常保存良好,这些患者的认知能力正常 (PD-NCC) 和轻度认知障碍 (PD-MCI).
- 在患有帕金森病痴呆症 (PDD) 的人群中,前侧注意系统的显著干扰是明显的.
- 这些发现强调了帕金森病认知衰退的严重程度与前侧注意力系统的完整性之间的明显关系.
相关概念视频
Parkinson's Disease: Treatment
945
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
945
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K


